These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 26797460

  • 1. Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.
    Sharma B, Varney ML, Saxena S, Wu L, Singh RK.
    Cancer Lett; 2016 Mar 28; 372(2):192-200. PubMed ID: 26797460
    [Abstract] [Full Text] [Related]

  • 2. IL-17-CXC Chemokine Receptor 2 Axis Facilitates Breast Cancer Progression by Up-Regulating Neutrophil Recruitment.
    Wu L, Awaji M, Saxena S, Varney ML, Sharma B, Singh RK.
    Am J Pathol; 2020 Jan 28; 190(1):222-233. PubMed ID: 31654638
    [Abstract] [Full Text] [Related]

  • 3. Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.
    Sharma B, Nawandar DM, Nannuru KC, Varney ML, Singh RK.
    Mol Cancer Ther; 2013 May 28; 12(5):799-808. PubMed ID: 23468530
    [Abstract] [Full Text] [Related]

  • 4. CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.
    Sharma B, Nannuru KC, Saxena S, Varney ML, Singh RK.
    Int J Mol Sci; 2019 Mar 12; 20(5):. PubMed ID: 30871004
    [Abstract] [Full Text] [Related]

  • 5. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
    Ruan JW, Liao YC, Lua I, Li MH, Hsu CY, Chen JH.
    Breast Cancer Res; 2012 Jul 12; 14(4):R106. PubMed ID: 22789011
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer patient-derived scaffolds as a tool to monitor chemotherapy responses in human tumor microenvironments.
    Leiva MC, Garre E, Gustafsson A, Svanström A, Bogestål Y, Håkansson J, Ståhlberg A, Landberg G.
    J Cell Physiol; 2021 Jun 12; 236(6):4709-4724. PubMed ID: 33368325
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
    Park SY, Kim MJ, Park SA, Kim JS, Min KN, Kim DK, Lim W, Nam JS, Sheen YY.
    Oncotarget; 2015 Nov 10; 6(35):37526-43. PubMed ID: 26462028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells.
    Jia D, Li L, Andrew S, Allan D, Li X, Lee J, Ji G, Yao Z, Gadde S, Figeys D, Wang L.
    Cell Death Dis; 2017 Jul 13; 8(7):e2932. PubMed ID: 28703802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin.
    Cheng Y, Mo F, Li Q, Han X, Shi H, Chen S, Wei Y, Wei X.
    Mol Cancer; 2021 Apr 04; 20(1):62. PubMed ID: 33814009
    [Abstract] [Full Text] [Related]

  • 13. Multiple anti-tumor effects of Reparixin on thyroid cancer.
    Liotti F, De Pizzol M, Allegretti M, Prevete N, Melillo RM.
    Oncotarget; 2017 May 30; 8(22):35946-35961. PubMed ID: 28415590
    [Abstract] [Full Text] [Related]

  • 14. CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways.
    Sobolik T, Su YJ, Wells S, Ayers GD, Cook RS, Richmond A.
    Mol Biol Cell; 2014 Mar 30; 25(5):566-82. PubMed ID: 24403602
    [Abstract] [Full Text] [Related]

  • 15. Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.
    Sharma B, Nannuru KC, Varney ML, Singh RK.
    Clin Exp Metastasis; 2015 Jan 30; 32(1):65-72. PubMed ID: 25511644
    [Abstract] [Full Text] [Related]

  • 16. EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models.
    Giró-Perafita A, Rabionet M, Planas M, Feliu L, Ciurana J, Ruiz-Martínez S, Puig T.
    Molecules; 2019 Mar 15; 24(6):. PubMed ID: 30875891
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer.
    Du R, Liu B, Zhou L, Wang D, He X, Xu X, Zhang L, Niu C, Liu S.
    Cell Death Dis; 2018 Jan 26; 9(2):126. PubMed ID: 29374148
    [Abstract] [Full Text] [Related]

  • 18. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.
    Miller-Kleinhenz J, Guo X, Qian W, Zhou H, Bozeman EN, Zhu L, Ji X, Wang YA, Styblo T, O'Regan R, Mao H, Yang L.
    Biomaterials; 2018 Jan 26; 152():47-62. PubMed ID: 29107218
    [Abstract] [Full Text] [Related]

  • 19. CXCL2/CXCR2 axis induces cancer stem cell characteristics in CPT-11-resistant LoVo colon cancer cells via Gαi-2 and Gαq/11.
    Chen MC, Baskaran R, Lee NH, Hsu HH, Ho TJ, Tu CC, Lin YM, Viswanadha VP, Kuo WW, Huang CY.
    J Cell Physiol; 2019 Jul 26; 234(7):11822-11834. PubMed ID: 30552676
    [Abstract] [Full Text] [Related]

  • 20. Ultrasound reverses chemoresistance in breast cancer stem cell like cells by altering ABCG2 expression.
    Guo L, Zheng P, Fan H, Wang H, Xu W, Zhou W.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 28935760
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.